SUNY Upstate Medical University

State University of New York

Syracuse, NY

Sorting 2 by

Accepting patients

MonumenTAL-6

64407564MMY3009: A Phase 3 Randomized Study Comparing Talquetamab in Combination With Pomalidomide (Tal-P), Talquetamab in Combination With Teclistamab (Tal-Tec), and Investigator's Choice of Either Elotuzumab, Pomalidomide, and Dexamethasone (EPd) or Pom
Learn more
  • Bispecific Antibody
  • GPRC5D
  • CD3
  • Randomization
  • Phase 3

Not currently accepting

EQUATE

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Learn more
  • Monoclonal Antibody
  • CD38
  • Phase 3